UBS Group’s Matinas BioPharma MTNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$92 Sell
184
-423
-70% -$265 ﹤0.01% 10131
2025
Q4
$356 Buy
607
+407
+204% +$480 ﹤0.01% 10009
2025
Q3
$378 Buy
200
+90
+82% +$129 ﹤0.01% 9709
2025
Q2
$98 Sell
110
-1,530
-93% -$1.12K ﹤0.01% 10008
2025
Q1
$853 Sell
1,640
-10,673
-87% -$6.32K ﹤0.01% 9640
2024
Q4
$6.28K Buy
12,313
+8,886
+259% +$13.5K ﹤0.01% 8572
2024
Q3
$12.1K Buy
+3,427
New +$21.8K ﹤0.01% 7647
2024
Q2
Sell
-898
Closed -$12.2K 9904
2024
Q1
$12.2K Buy
+898
New +$10.7K ﹤0.01% 7149
2023
Q3
Sell
-286
Closed -$5.15K 9794
2023
Q2
$5.15K Buy
+286
New +$6.67K ﹤0.01% 7469
2023
Q1
Sell
-237
Closed -$5.93K 10080
2022
Q4
$5.93K Buy
+237
New +$7.88K ﹤0.01% 9108
2021
Q4
Sell
-206
Closed -$13K 10535
2021
Q3
$13K Buy
206
+155
+304% +$6.69K ﹤0.01% 7672
2021
Q2
$2K Sell
51
-299
-85% -$12.9K ﹤0.01% 8963
2021
Q1
$18K Buy
350
+316
+929% +$21.2K ﹤0.01% 7467
2020
Q4
$2K Sell
34
-2,830
-99% -$131K ﹤0.01% 8105
2020
Q3
$110K Buy
2,864
+657
+30% +$26.1K ﹤0.01% 5126
2020
Q2
$85K Buy
2,207
+2,042
+1,238% +$78.3K ﹤0.01% 5427
2020
Q1
$5K Buy
165
+93
+129% +$5.62K ﹤0.01% 7302
2019
Q4
$8K Buy
+72
New +$4.17K ﹤0.01% 7392
2019
Q2
Sell
-216
Closed -$12K 8048
2019
Q1
$12K Sell
216
-252
-54% -$13.6K ﹤0.01% 6687
2018
Q4
$14K Buy
+468
New +$18.4K ﹤0.01% 7043
2018
Q3
Sell
-88
Closed -$2K 8150
2018
Q2
$2K Buy
+88
New +$2.54K ﹤0.01% 7733
2018
Q1
Sell
-219
Closed -$13K 8037
2017
Q4
$13K Buy
219
+96
+78% +$6.17K ﹤0.01% 6868
2017
Q3
$9K Sell
123
-653
-84% -$43.6K ﹤0.01% 6952
2017
Q2
$66K Buy
776
+706
+1,009% +$94.8K ﹤0.01% 5463
2017
Q1
$10K Buy
+70
New +$11.4K ﹤0.01% 6615

Other funds holding MTNB